506 related articles for article (PubMed ID: 29264533)
1. Targeting NAD+ in Metabolic Disease: New Insights Into an Old Molecule.
Elhassan YS; Philp AA; Lavery GG
J Endocr Soc; 2017 Jul; 1(7):816-835. PubMed ID: 29264533
[TBL] [Abstract][Full Text] [Related]
2. Regulatory Effects of NAD
Zhang N; Sauve AA
Prog Mol Biol Transl Sci; 2018; 154():71-104. PubMed ID: 29413178
[TBL] [Abstract][Full Text] [Related]
3. Implications of altered NAD metabolism in metabolic disorders.
Okabe K; Yaku K; Tobe K; Nakagawa T
J Biomed Sci; 2019 May; 26(1):34. PubMed ID: 31078136
[TBL] [Abstract][Full Text] [Related]
4. TNB-738, a biparatopic antibody, boosts intracellular NAD+ by inhibiting CD38 ecto-enzyme activity.
Ugamraj HS; Dang K; Ouisse LH; Buelow B; Chini EN; Castello G; Allison J; Clarke SC; Davison LM; Buelow R; Deng R; Iyer S; Schellenberger U; Manika SN; Bijpuria S; Musnier A; Poupon A; Cuturi MC; van Schooten W; Dalvi P
MAbs; 2022; 14(1):2095949. PubMed ID: 35867844
[TBL] [Abstract][Full Text] [Related]
5. NAD+ and sirtuins in aging and disease.
Imai S; Guarente L
Trends Cell Biol; 2014 Aug; 24(8):464-71. PubMed ID: 24786309
[TBL] [Abstract][Full Text] [Related]
6. Role of Nicotinamide Adenine Dinucleotide and Related Precursors as Therapeutic Targets for Age-Related Degenerative Diseases: Rationale, Biochemistry, Pharmacokinetics, and Outcomes.
Braidy N; Berg J; Clement J; Khorshidi F; Poljak A; Jayasena T; Grant R; Sachdev P
Antioxid Redox Signal; 2019 Jan; 30(2):251-294. PubMed ID: 29634344
[No Abstract] [Full Text] [Related]
7. NAD
Xu J; Kitada M; Koya D
Front Med (Lausanne); 2021; 8():703076. PubMed ID: 34368195
[TBL] [Abstract][Full Text] [Related]
8. The Clock-NAD
Aggarwal S; Trehanpati N; Nagarajan P; Ramakrishna G
J Cell Physiol; 2022 Aug; 237(8):3164-3180. PubMed ID: 35616339
[TBL] [Abstract][Full Text] [Related]
9. Nicotinamide adenine dinucleotide (NAD+): essential redox metabolite, co-substrate and an anti-cancer and anti-ageing therapeutic target.
Griffiths HBS; Williams C; King SJ; Allison SJ
Biochem Soc Trans; 2020 Jun; 48(3):733-744. PubMed ID: 32573651
[TBL] [Abstract][Full Text] [Related]
10. Emerging therapeutic roles for NAD(+) metabolism in mitochondrial and age-related disorders.
Srivastava S
Clin Transl Med; 2016 Dec; 5(1):25. PubMed ID: 27465020
[TBL] [Abstract][Full Text] [Related]
11. Nicotinamide adenine dinucleotide homeostasis and signalling in heart disease: Pathophysiological implications and therapeutic potential.
Mericskay M
Arch Cardiovasc Dis; 2016 Mar; 109(3):207-15. PubMed ID: 26707577
[TBL] [Abstract][Full Text] [Related]
12. Nicotinamide adenine dinucleotide: Biosynthesis, consumption and therapeutic role in cardiac diseases.
Tannous C; Booz GW; Altara R; Muhieddine DH; Mericskay M; Refaat MM; Zouein FA
Acta Physiol (Oxf); 2021 Mar; 231(3):e13551. PubMed ID: 32853469
[TBL] [Abstract][Full Text] [Related]
13. NAD⁺ in aging, metabolism, and neurodegeneration.
Verdin E
Science; 2015 Dec; 350(6265):1208-13. PubMed ID: 26785480
[TBL] [Abstract][Full Text] [Related]
14. Nicotinamide mononucleotide alters mitochondrial dynamics by SIRT3-dependent mechanism in male mice.
Klimova N; Long A; Kristian T
J Neurosci Res; 2019 Aug; 97(8):975-990. PubMed ID: 30801823
[TBL] [Abstract][Full Text] [Related]
15. NAD⁺ metabolism: a therapeutic target for age-related metabolic disease.
Mouchiroud L; Houtkooper RH; Auwerx J
Crit Rev Biochem Mol Biol; 2013; 48(4):397-408. PubMed ID: 23742622
[TBL] [Abstract][Full Text] [Related]
16. Modulating Sirtuin Biology and Nicotinamide Adenine Diphosphate Metabolism in Cardiovascular Disease-From Bench to Bedside.
Wang YJ; Paneni F; Stein S; Matter CM
Front Physiol; 2021; 12():755060. PubMed ID: 34712151
[TBL] [Abstract][Full Text] [Related]
17. A new facet of ADP-ribosylation reactions: SIRTs and PARPs interplay.
Faraone-Mennella MR
Front Biosci (Landmark Ed); 2015 Jan; 20(3):458-73. PubMed ID: 25553461
[TBL] [Abstract][Full Text] [Related]
18. NAD
Covarrubias AJ; Perrone R; Grozio A; Verdin E
Nat Rev Mol Cell Biol; 2021 Feb; 22(2):119-141. PubMed ID: 33353981
[TBL] [Abstract][Full Text] [Related]
19. NAD Precursors, Mitochondria Targeting Compounds and ADP-Ribosylation Inhibitors in Treatment of Inflammatory Diseases and Cancer.
Poltronieri P; Mezzolla V; Farooqi AA; Di Girolamo M
Curr Med Chem; 2021; 28(41):8453-8479. PubMed ID: 33461448
[TBL] [Abstract][Full Text] [Related]
20. The Regulatory Role of NAD in Human and Animal Cells.
Kulikova VA; Gromyko DV; Nikiforov AA
Biochemistry (Mosc); 2018 Jul; 83(7):800-812. PubMed ID: 30200865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
